RecruitingPhase 4NCT07193849

Zinc Oxide VS MEBO

Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial

Sponsor

King Abdullah Medical City

Enrollment

76 participants

Start Date

Dec 31, 2023

Study Type

INTERVENTIONAL

Conditions

pressure injury Pressure Ulcers Stage II Pressure Injury Stage 2 Bedsore Pressure Ulcer, Buttock

Summary

randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called MEBO Wound Ointment and a drug called zinc oxide for people with bedsore, pressure injury stage 2, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.